Martens and Juan Antonio Vizcaino, head of the PRIDE mass spectrometry data archive at the European Bioinformatics Institute, recently co-authored a commentary on the topic.
Launching a diverse product pipeline will also test Helix's ability to manage the challenges of providing genomics interpretations to a broad consumer audience.
The company offers what it calls an "end-to-end solution" for assembling study cohorts, tackling a challenging part of the diagnostic development process.
An epigenetic analysis showed that the tumors all shared a certain DNA methylation signature, but that methylation patterns varied between samples.
Agilent filed a lawsuit against Twist nearly a year ago, alleging that Twist Cofounder and CEO Emily LeProust had stolen DNA oligonucleotide synthesis technology.
Guardant will help MD Anderson develop new assays and conduct clinical studies, and physicians will be able to order the company's test through an EMR system.
The coverage decision provides Humana's 13 million members with access to the test, which provides a numerical score to assess the risk of disease recurrence.
The two companies are expanding a long-term collaboration to include development and commercialization of assays for the Applied Biosystems 3500Dx system.
A new study from researchers at UCSF and Kaiser Permanente has uncovered a set of genes that appear to regulate natural variations in prostate-specific antigen.
As part of a broader analysis, Genome 10K researchers compared hummingbird genome assemblies with Phase Genomics Hi-C and Dovetail Genomics Hi-C.
The European Commission has now approved the anti-PD-1 therapy Keytruda, and the Dako test with it, as a first-line treatment for non-small cell lung cancer.
Research software firm Benchling has announced the release of its Molecular Biology 2.0 system.
The extension to its platform incorporates batch sequence design, CRISPR design, protein design, alignment tools, and cloning software into its digital lab notebook, enabling high-throughput antibody engineering and CRISPR design.
A new study suggests that more than 1 percent of the Mongolian yak genome, on average, is made up of sequences obtained by mixing with bovine cattle.
A study by Brazilian researchers identified cellular processes affected by the virus that could explain the brain malformations associated with the disease.
A number of these loci were linked to blood pressure medication targets, and the researchers developed a genetic risk score.
The partners aim to identify master regulators in the molecular networks of GIST patients that can serve as drug targets for existing treatments.